A novel thermostable RNase HI sequence mutant, its preparation method, and its application.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- BEIJING TRANSGEN BIOTECH CO LTD
- Filing Date
- 2026-01-15
- Publication Date
- 2026-06-30
AI Technical Summary
Existing thermostable RNase HI has low heterologous expression levels and high production costs, making it difficult to meet the needs of molecular biology applications under high-temperature reaction conditions.
A novel sequence mutant of thermostable RNase HI was designed by fusing a new sequence to the carboxyl terminus of wild-type thermostable RNase HI. The mutant was then overexpressed and purified using the recombinant expression plasmid pET-21a-RNaseHIMut1, including PEI precipitation, Ni affinity chromatography, and ion exchange chromatography, to enhance enzyme activity and thermostable properties.
It significantly improved the heterologous expression level and enzyme activity of thermostable RNase HI, reduced production costs, and is suitable for molecular biology applications under high-temperature reaction conditions.
Smart Images

Figure CN121801868B_ABST